Posted inBiotechnology
New EAMA highlights showcase 30-year cohort generation research findings
Thirty years after a small group of European professors of geriatric medicine first warned that the continent’s fastest-growing population was…
Posted inBiotechnology
Hepatitis C Care Can Learn Key Lessons from the US HIV Epidemic
A silent liver-destroying virus continues to spread across the United States at an accelerating pace, even though the drugs that…
Posted inBiotechnology
DCLK1 drives fibroblast activation and lung fibrosis via Smad3 binding
Idiopathic pulmonary fibrosis, a relentlessly progressive and fatal scarring disease of the lungs, has long frustrated clinicians with only two…
Posted inBiotechnology
ZEB1 Drives Epithelial-Mesenchymal Transition and Hormone Resistance in Endometriosis
Endometriosis, a chronic inflammatory condition affecting an estimated one in ten women of reproductive age, has long frustrated clinicians with…
Posted inBiotechnology
Simulating Fluid–Structure Interaction in Eyes with Detached Descemet Membrane
In a finding that could reshape how ophthalmologists think about one of the most delicate complications of corneal surgery, a…
Posted inBiotechnology
Virtual screening uncovers tepotinib as LY75 inhibitor against ovarian cancer
In a finding that could reshape the search for new treatments against one of the deadliest gynecologic malignancies, researchers in…
Posted inBiotechnology
Integrated Chromosomal and Bioinformatics Analysis Reveals Genetic Causes of Recurrent Pregnancy Loss
Recurrent pregnancy loss affects an estimated one in a hundred couples trying to build a family, yet in a striking…
Posted inBiotechnology
How systemic inflammation drives muscle dysfunction in COPD exercise
A sweeping new narrative review published in the Journal of Translational Medicine is pulling back the curtain on one of…
Posted inBiotechnology
Biohaven epilepsy drug suffers FDA hold days after attracting $350M deal
The FDA has put enrollment in trials of Biohaven’s epilepsy drug candidate BHV-7000 on hold in response to findings from…
Posted inBiotechnology
Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs
Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment, netting more than $1.1 billion for its long-running…